[go: up one dir, main page]

RS57850B1 - Stabilizovane formulacije koje sadrže antitela protiv interleukin-4 receptora (il-4r) - Google Patents

Stabilizovane formulacije koje sadrže antitela protiv interleukin-4 receptora (il-4r)

Info

Publication number
RS57850B1
RS57850B1 RS20181308A RSP20181308A RS57850B1 RS 57850 B1 RS57850 B1 RS 57850B1 RS 20181308 A RS20181308 A RS 20181308A RS P20181308 A RSP20181308 A RS P20181308A RS 57850 B1 RS57850 B1 RS 57850B1
Authority
RS
Serbia
Prior art keywords
interleukin
antibodies
receptor
formulations containing
containing anti
Prior art date
Application number
RS20181308A
Other languages
English (en)
Serbian (sr)
Inventor
Daniel B Dix
Xiaolin Tang
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Priority claimed from EP11770625.9A external-priority patent/EP2624865B1/en
Publication of RS57850B1 publication Critical patent/RS57850B1/sr

Links

RS20181308A 2010-10-06 2011-10-05 Stabilizovane formulacije koje sadrže antitela protiv interleukin-4 receptora (il-4r) RS57850B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06
EP11770625.9A EP2624865B1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
PCT/US2011/054856 WO2012047954A1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Publications (1)

Publication Number Publication Date
RS57850B1 true RS57850B1 (sr) 2018-12-31

Family

ID=45995014

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20181308A RS57850B1 (sr) 2010-10-06 2011-10-05 Stabilizovane formulacije koje sadrže antitela protiv interleukin-4 receptora (il-4r)

Country Status (14)

Country Link
AR (1) AR083338A1 (lt)
DK (2) DK2624865T3 (lt)
ES (2) ES2820246T3 (lt)
HK (1) HK1258305A1 (lt)
HR (1) HRP20181822T1 (lt)
HU (1) HUE052089T2 (lt)
LT (1) LT2624865T (lt)
PT (1) PT3354280T (lt)
RS (1) RS57850B1 (lt)
SI (1) SI2624865T1 (lt)
SM (1) SMT201800488T1 (lt)
TW (7) TWI498121B (lt)
UA (1) UA111731C2 (lt)
UY (1) UY33652A (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015003590A8 (pt) 2012-08-21 2017-10-31 Sanofi Sa Métodos para tratamento ou prevenção da asma por administração de um antagonista de il-4r
HUE046410T2 (hu) * 2013-06-21 2020-03-30 Sanofi Biotechnology Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával
AU2014284235B2 (en) * 2013-06-21 2019-11-21 Regeneron Pharmaceuticals, Inc. Methods for treating nasal polyposis by administering an IL-4R antagonist
WO2016077675A1 (en) 2014-11-14 2016-05-19 Sanofi Biotechnology Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
PL3703818T3 (pl) 2017-10-30 2024-03-25 Sanofi Biotechnology Antagonista IL-4R do zastosowania w sposobie leczenia lub zapobiegania astmie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (es) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% Sistema de alineacion de patrones en un sustrato mediante litografia por estencil.
KR101593726B1 (ko) * 2008-09-10 2016-02-18 니혼 엑스란 고교 (주) 가교 아크릴레이트계 섬유 및 이의 제조방법
CA2754528A1 (en) * 2009-03-06 2010-09-10 Genetech, Inc. Antibody formulation

Also Published As

Publication number Publication date
HK1258305A1 (zh) 2019-11-08
TW201716086A (zh) 2017-05-16
TW202320851A (zh) 2023-06-01
PT3354280T (pt) 2020-09-01
HUE052089T2 (hu) 2021-04-28
DK3354280T3 (da) 2020-09-28
SMT201800488T1 (it) 2018-11-09
TW202026011A (zh) 2020-07-16
TWI690329B (zh) 2020-04-11
TW202102262A (zh) 2021-01-16
UY33652A (es) 2012-04-30
TWI856388B (zh) 2024-09-21
TW201221141A (en) 2012-06-01
ES2687813T3 (es) 2018-10-29
HRP20181822T1 (hr) 2018-12-28
ES2820246T3 (es) 2021-04-20
TWI718890B (zh) 2021-02-11
TW201542229A (zh) 2015-11-16
TWI498121B (zh) 2015-09-01
TWI782325B (zh) 2022-11-01
SI2624865T1 (sl) 2018-10-30
TWI679988B (zh) 2019-12-21
DK2624865T3 (en) 2018-10-22
TW201924718A (zh) 2019-07-01
AR083338A1 (es) 2013-02-21
LT2624865T (lt) 2018-10-25
UA111731C2 (uk) 2016-06-10
TWI568445B (zh) 2017-02-01

Similar Documents

Publication Publication Date Title
IL283424B1 (en) Stabilized formulations that include antibodies against the interleukin receptor (il-4r)
HRP20181821T1 (hr) Stabilizirani pripravci koji sadrže anti-interleukin-6 receptorska (il-6r) antitijela
IL265501A (en) Stabilized liquid formulations containing antibody
SI3409289T1 (sl) Stabilni sestavki, ki vsebujejo protitelo
HK1258305A1 (zh) 含有抗白介素-4受體(il-4r)的抗體的穩定製劑
EP2588141A4 (en) ANTIBODY FORMULATIONS